Medscape Psychopharmacology Today

Promotional Talks for the Pharmaceutical Industry Thomas A. M. Kramer, MD, offers his view on the new requirements surrounding promotional talks for the pharmaceutical industry.
Journal Article, July 27, 2004
Psychopharmacology in The New York Times Thomas A. M. Kramer, MD, discusses some of the topical psychopharmacology articles recently covered in The New York Times.
Journal Article, June 24, 2004
All the Things They Taught Us That Were Wrong This column seeks to debunk the many myths of psychopharmacology.
Journal Article, May 04, 2004
Talking Points About Antidepressants and Suicide It is important to describe the issues surrounding antidepressants and suicide in context.
Journal Article, April 15, 2004
A Plea for Biased Information It is time to understand that biased information is everywhere. Clinicians need to review pharmaceutical information in context.
Journal Article, February 11, 2004
Guest Column: Rebuttal to Gatekeepers to Pharmaceuticals Making more medications, particularly psychotropics such as antidepressants, available over the counter is not the solution and would almost certainly create more problems than it would solve.
Journal Article, December 19, 2003
Gatekeepers to Pharmaceuticals Millions and millions of dollars are being spent just to tell our patients to talk to us.
Journal Article, November 14, 2003
Understanding Clinical Trials in Context It is important for clinicians to know about the realities of the world of clinical studies and how to read between the data.
Journal Article, October 03, 2003
Do Medications Really Expire? A question that everyone asks but, until now, was often inadequately answered.
Journal Article, August 22, 2003
Choosing Which Drug to Prescribe Although we are quite good as a field at coming up with new medications, we are not as good at developing some kind of methodology for choosing between them.
Journal Article, August 07, 2003
A Conversation With a Colleague The latest Medscape Psychiatry psychopharmacology column
Journal Article, July 11, 2003
Why Some Drugs Work and Others Do Not Understanding the unpredictability of clinical responses to medications
Journal Article, May 07, 2003
Dual Diagnoses, New Perspectives A different look at dual diagnosis patients
Journal Article, March 25, 2003
Side Effects and Therapeutic Effects Understanding side effects in drugs
Journal Article, January 30, 2003
A Field of Increasing Possibilities Understanding the off-label process
Journal Article, December 18, 2002
Medscape Psychopharmacology Today Development process for drugs
Journal Article, July 25, 2002
Psychiatry Psychopharmacology Column Relationships with pharmaceutical companies
Journal Article, May 10, 2002
Dopamine System Stabilizers More new-generation antipsychotics
Journal Article, March 18, 2002
Endogenous Versus Exogenous: Still Not the Issue It is time to rethink psychiatry from the inside out!
Journal Article, January 18, 2002
Polypharmacy-in-a-Pill Do atypical antipsychotics represent an important clinical advance over the older typical antipsychotics?
Journal Article, March 01, 2001

No Results